Morgan Stanley analyst Brian Nowak lowered the firm’s price target on Integral Ad Science (IAS) to $16.50 from $21.50 and keeps an Overweight rating on the shares. Integral posted a “strong” Q3 beat, but the firm has marked its valuation to market with its closest peer DoubleVerify (DV), which has declined about 20% since the firm had last updated its Integral price target, the analyst tells investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on IAS:
- IAS Reports Third Quarter 2023 Financial Results
- Integral Ad Science raises FY23 revenue view to $470M-$472M from $459M-$465M
- Integral Ad Science sees Q4 revenue $130M-$132M, consensus $130.02M
- Integral Ad Science reports Q3 EPS (9c), consensus 0c
- Integral Ad Science price target lowered to $20 from $23 at Stifel